NRSN News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-08-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-08-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-07-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-07-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-07-22 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-06-29 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-06-25 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-06-11 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-06-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-06-08 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-04-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-04-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-04-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-04-03 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-03-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-03-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-03-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-03-11 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-02-18 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-02-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-02-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2026-01-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-12-22 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-12-08 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-12-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-11-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-11-21 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-10-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-09-25 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-09-10 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-09-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-09-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-09-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-08-21 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-08-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-08-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-07-10 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-06-26 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-05-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-04-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-04-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-03-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-03-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-02-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2025-01-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-23 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-18 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-17 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-11 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-12-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-11-12 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-30 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-10-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-09-30 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-09-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-09-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-09-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-30 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-26 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-08-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-07-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-07-03 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-07-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-06-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-06-24 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-06-21 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-06-17 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-05-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-05-23 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-05-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-05-14 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-05-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-04-12 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-04-10 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-04-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-04-05 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-02-22 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-02-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-01-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2024-01-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-12-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-12-21 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-12-14 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-12-05 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-11-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-11-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-11-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-10-17 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-10-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-10-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-09-29 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |